This work is licensed under the Creative Commons Attribution 4.0 International License.
Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev. Cancer. 2017; 17:528–42.LevyJMMTowersCGThorburnATargeting autophagy in cancerNat Rev. Cancer2017175284210.1038/nrc.2017.53597536728751651Search in Google Scholar
White E. The role for autophagy in cancer. J Clin Investig. 2015; 125:42–6.WhiteEThe role for autophagy in cancerJ Clin Investig201512542610.1172/JCI73941438224725654549Search in Google Scholar
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646–74.HanahanDWeinbergRAHallmarks of cancer: the next generationCell20111446467410.1016/j.cell.2011.02.01321376230Search in Google Scholar
Cheong H. Chapter 23. Role of autophagy in cancer metabolism. In: Gorbunov NV, Schneider M, editors. Autophagy in current trends in cellular physiology and pathology. London: IntechOpen; 2016, p. 499–514. doi: 10.5772/64025CheongHChapter 23. Role of autophagy in cancer metabolismIn:GorbunovNVSchneiderMeditors.Autophagy in current trends in cellular physiology and pathologyLondonIntechOpen201649951410.5772/64025Open DOISearch in Google Scholar
Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451(7182):1069–75.MizushimaNLevineBCuervoAMKlionskyDJAutophagy fights disease through cellular self-digestionNature2008451718210697510.1038/nature06639267039918305538Search in Google Scholar
Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009; 10:458–67.NakatogawaHSuzukiKKamadaYOhsumiYDynamics and diversity in autophagy mechanisms: lessons from yeastNat Rev Mol Cell Biol2009104586710.1038/nrm270819491929Search in Google Scholar
Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002; 27:421–9.MizushimaNOhsumiYYoshimoriTAutophagosome formation in mammalian cellsCell Struct Funct200227421910.1247/csf.27.42112576635Search in Google Scholar
Wang X, Zhang X, Dong X-P, Samie M, Li X, Cheng X, et al. TPC proteins are phosphoinositide-activated sodium-selective ion channels in endosomes and lysosomes. Cell. 2012; 151:372–83.WangXZhangXDongX-PSamieMLiXChengXTPC proteins are phosphoinositide-activated sodium-selective ion channels in endosomes and lysosomesCell20121513728310.1016/j.cell.2012.08.036347518623063126Search in Google Scholar
Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018; 19:365–81.KaushikSCuervoAMThe coming of age of chaperone-mediated autophagyNat Rev Mol Cell Biol2018193658110.1038/s41580-018-0001-6639951829626215Search in Google Scholar
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020; 19:12. doi: 10.1186/s12943-020-1138-4LiXHeSMaBAutophagy and autophagy-related proteins in cancerMol Cancer2020191210.1186/s12943-020-1138-4697507031969156Open DOISearch in Google Scholar
Li Y, Chen Y. Chapter 4. AMPK and autophagy. In: Qin Z-H, editor. Autophagy: biology and diseases. Beijing: Science Press, and Singapore: Springer Nature; 2019, p. 85–108. (Crusio WE, Lambris JD, Rezaei N, series editors, Adv Exp Med Biol., vol. 1206). doi: 10.1007/978-981-15-0602-4_4LiYChenYChapter 4. AMPK and autophagyIn:QinZ-Heditor.Autophagy: biology and diseasesBeijingScience Press, and Singapore: Springer Nature201985108(Crusio WE, Lambris JD, Rezaei N, series editors, Adv Exp Med Biol., vol. 1206).10.1007/978-981-15-0602-4_431776981Open DOISearch in Google Scholar
Al-Bari MAA, Xu P. Molecular regulation of autophagy machinery by mTOR-dependent and-independent pathways. Ann NY Acad Sci. 2020; 1467:3–20.Al-BariMAAXuPMolecular regulation of autophagy machinery by mTOR-dependent and-independent pathwaysAnn NY Acad Sci2020146732010.1111/nyas.1430531985829Search in Google Scholar
Chen X, Li S, Li D, Li M, Su Z, Lai X, et al. Ethanol extract of Brucea javanica seed inhibit triple-negative breast cancer by restraining autophagy via PI3K/Akt/mTOR pathway. Front Pharmacol. 2020; 11:606. doi: 10.3389/fphar.2020.00606ChenXLiSLiDLiMSuZLaiXEthanol extract of Brucea javanica seed inhibit triple-negative breast cancer by restraining autophagy via PI3K/Akt/mTOR pathwayFront Pharmacol20201160610.3389/fphar.2020.00606720104332411003Open DOISearch in Google Scholar
Seabright AP, Fine NH, Barlow JP, Lord SO, Musa I, Gray A, et al. AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner. FASEB J. 2020; 34:6284–301.SeabrightAPFineNHBarlowJPLordSOMusaIGrayAAMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent mannerFASEB J202034628430110.1096/fj.201903051R721201932201986Search in Google Scholar
Movahhed P, Saberiyan M, Safi A, Arshadi Z, Kazerouni F, Teimori H. The impact of DAPK1 and mTORC1 signaling association on autophagy in cancer. Mol Biol Rep. 2022; 49:4959–64.MovahhedPSaberiyanMSafiAArshadiZKazerouniFTeimoriHThe impact of DAPK1 and mTORC1 signaling association on autophagy in cancerMol Biol Rep20224949596410.1007/s11033-022-07154-135083613Search in Google Scholar
Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol. 2011; 12:295–303.DelgoffeGMPollizziKNWaickmanATHeikampEMeyersDJHortonMRThe kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2Nat Immunol20111229530310.1038/ni.2005307782121358638Search in Google Scholar
Feng Y, Kang HH, Wong P-M, Gao M, Wang P, Jiang X. Unc-51-like kinase (ULK) complex-independent autophagy induced by hypoxia. Protein Cell. 2019; 10:376–81.FengYKangHHWongP-MGaoMWangPJiangXUnc-51-like kinase (ULK) complex-independent autophagy induced by hypoxiaProtein Cell2019103768110.1007/s13238-018-0584-x646804130374937Search in Google Scholar
Cheong H, Nair U, Geng J, Klionsky DJ. The ATG1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecific autophagy in Saccharomyces cerevisiae. Mol Biol Cell. 2008; 19:668–81.CheongHNairUGengJKlionskyDJThe ATG1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecific autophagy in Saccharomyces cerevisiaeMol Biol Cell2008196688110.1091/mbc.e07-08-0826223059218077553Search in Google Scholar
Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008; 19:5360–72.ItakuraEKishiCInoueKMizushimaNBeclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAGMol Biol Cell20081953607210.1091/mbc.e08-01-0080259266018843052Search in Google Scholar
Suzuki K, Akioka M, Kondo-Kakuta C, Yamamoto H, Ohsumi Y. Fine mapping of autophagy-related proteins during autophagosome formation in Saccharomyces cerevisiae. J Cell Sci. 2013; 126:2534–44.SuzukiKAkiokaMKondo-KakutaCYamamotoHOhsumiYFine mapping of autophagy-related proteins during autophagosome formation in Saccharomyces cerevisiaeJ Cell Sci201312625344410.1242/jcs.12296023549786Search in Google Scholar
Wijdeven RH, Janssen H, Nahidiazar L, Janssen L, Jalink K, Berlin I, Neefjes J. Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway. Nat Commun. 2016; 7:11808. doi: 10.1038/ncomms11808WijdevenRHJanssenHNahidiazarLJanssenLJalinkKBerlinINeefjesJCholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathwayNat Commun201671180810.1038/ncomms11808490641127283760Open DOISearch in Google Scholar
Kimura S, Noda T, Yoshimori T. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct. 2008; 33:109–22.KimuraSNodaTYoshimoriTDynein-dependent movement of autophagosomes mediates efficient encounters with lysosomesCell Struct Funct2008331092210.1247/csf.0800518388399Search in Google Scholar
Gąsiorkiewicz BM, Koczurkiewicz-Adamczyk P, Piska K, Pękala E. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer. Invest New Drugs. 2021; 39:538–63.GąsiorkiewiczBMKoczurkiewicz-AdamczykPPiskaKPękalaEAutophagy modulating agents as chemosensitizers for cisplatin therapy in cancerInvest New Drugs2021395386310.1007/s10637-020-01032-y796062433159673Search in Google Scholar
Flynn ALB, Schiemann WP. Autophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions? J Cancer Metastatis Treat. 2019; 5:43. doi: 10.20517/2394-4722.2019.13FlynnALBSchiemannWPAutophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions?J Cancer Metastatis Treat201954310.20517/2394-4722.2019.13670185031431926Open DOISearch in Google Scholar
Wu J, Ye J, Xie Q, Liu B, Liu M. Targeting regulated cell death with pharmacological small molecules: an update on autophagy-dependent cell death, ferroptosis, and necroptosis in cancer: miniperspective. J Med Chem. 2022; 65:2989–3001.WuJYeJXieQLiuBLiuMTargeting regulated cell death with pharmacological small molecules: an update on autophagy-dependent cell death, ferroptosis, and necroptosis in cancer: miniperspectiveJ Med Chem2022652989300110.1021/acs.jmedchem.1c0157235130435Search in Google Scholar
Ravichandran R, PriyaDharshini LC, Sakthivel KM, Rasmi RR. Role and regulation of autophagy in cancer. Biochim Biophys Acta Mol Basis Dis. 2022; 1868:166400. doi: 10.1016/j.bbadis.2022.166400RavichandranRPriyaDharshiniLCSakthivelKMRasmiRRRole and regulation of autophagy in cancerBiochim Biophys Acta Mol Basis Dis2022186816640010.1016/j.bbadis.2022.16640035341960Open DOISearch in Google Scholar
Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018; 19:3466. doi: 10.3390/ijms19113466YunCWLeeSHThe roles of autophagy in cancerInt J Mol Sci201819346610.3390/ijms19113466627480430400561Open DOISearch in Google Scholar
Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen H-Y, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009; 137:1062–75.MathewRKarpCMBeaudoinBVuongNChenGChenH-YAutophagy suppresses tumorigenesis through elimination of p62Cell200913710627510.1016/j.cell.2009.03.048280231819524509Search in Google Scholar
White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009; 15:5308–16.WhiteEDiPaolaRSThe double-edged sword of autophagy modulation in cancerClin Cancer Res20091553081610.1158/1078-0432.CCR-07-5023273708319706824Search in Google Scholar
Singh SS, Vats S, Chia AY-Q, Tan TZ, Deng S, Ong MS, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018; 37:1142–58.SinghSSVatsSChiaAY-QTanTZDengSOngMSDual role of autophagy in hallmarks of cancerOncogene20183711425810.1038/s41388-017-0046-629255248Search in Google Scholar
Cristofani R, Marelli MM, Cicardi ME, Fontana F, Marzagalli M, Limonta P, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells. Cell Death Dis. 2018; 9:889. doi: 10.1038/s41419-018-0866-5CristofaniRMarelliMMCicardiMEFontanaFMarzagalliMLimontaPDual role of autophagy on docetaxel-sensitivity in prostate cancer cellsCell Death Dis2018988910.1038/s41419-018-0866-5611730030166521Open DOISearch in Google Scholar
Patra S, Pradhan B, Nayak R, Behera C, Panda KC, Das S, et al. Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: current evidences and future perspectives. Phytother Res. 2021; 35:4194–214.PatraSPradhanBNayakRBeheraCPandaKCDasSApoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: current evidences and future perspectivesPhytother Res202135419421410.1002/ptr.708233749909Search in Google Scholar
Perez-Mancera PA, Young AR, Narita M. Inside and out: the activities of senescence in cancer. Nat Rev Cancer. 2014; 14:547–58.Perez-ManceraPAYoungARNaritaMInside and out: the activities of senescence in cancerNat Rev Cancer2014145475810.1038/nrc377325030953Search in Google Scholar
Saoudaoui S, Bernard M, Cardin GB, Malaquin N, Christopoulos A, Rodier F. mTOR as a senescence manipulation target: a forked road. Adv Cancer Res. 2021; 150:335–63.SaoudaouiSBernardMCardinGBMalaquinNChristopoulosARodierFmTOR as a senescence manipulation target: a forked roadAdv Cancer Res20211503356310.1016/bs.acr.2021.02.00233858600Search in Google Scholar
Patel NH, Bloukh S, Alwohosh E, Alhesa A, Saleh T, Gewirtz DA. Chapter 1. Autophagy and senescence in cancer therapy. In: Gewirtz DA, Fisher PB, editors. Autophagy and senescence in cancer therapy. San Diego: Academic Press; 2021, p. 1–74. (series, Adv Cancer Res., Vol. 150)PatelNHBloukhSAlwohoshEAlhesaASalehTGewirtzDAChapter 1. Autophagy and senescence in cancer therapyIn:GewirtzDAFisherPBeditors.Autophagy and senescence in cancer therapySan DiegoAcademic Press2021174(series, Adv Cancer Res., Vol. 150)10.1016/bs.acr.2021.01.00233858594Search in Google Scholar
Liu EY, Ryan KM. Autophagy and cancer – issues we need to digest. J Cell Sci. 2012; 125:2349–58.LiuEYRyanKMAutophagy and cancer – issues we need to digestJ Cell Sci201212523495810.1242/jcs.09370822641689Search in Google Scholar
Ding Z-B, Shi Y-H, Zhou J, Qiu S-J, Xu Y, Dai Z, et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008; 68:9167–75.DingZ-BShiY-HZhouJQiuS-JXuYDaiZAssociation of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinomaCancer Res20086891677510.1158/0008-5472.CAN-08-157319010888Search in Google Scholar
Furuya N, Yu J, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy, and tumor suppressor function. Autophagy. 2005; 1:46–52.FuruyaNYuJByfieldMPattingreSLevineBThe evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy, and tumor suppressor functionAutophagy20051465210.4161/auto.1.1.154216874027Search in Google Scholar
Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011; 25:795–800.TakamuraAKomatsuMHaraTSakamotoAKishiCWaguriSAutophagy-deficient mice develop multiple liver tumorsGenes Dev20112579580010.1101/gad.2016211307870521498569Search in Google Scholar
An CH, Kim MS, Yoo NJ, Park SW, Lee SH. Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers. Pathol Res Pract. 2011; 207:433–7.AnCHKimMSYooNJParkSWLeeSHMutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancersPathol Res Pract2011207433710.1016/j.prp.2011.05.00221664058Search in Google Scholar
Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol. 2007; 9:1142–51.TakahashiYCoppolaDMatsushitaNCualingHDSunMSatoYBif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesisNat Cell Biol2007911425110.1038/ncb1634225452117891140Search in Google Scholar
Rodgers MA, Bowman JW, Liang Q, Jung JU. Regulation where autophagy intersects the inflammasome. Antioxid Redox Signal. 2014; 20:495–506.RodgersMABowmanJWLiangQJungJURegulation where autophagy intersects the inflammasomeAntioxid Redox Signal20142049550610.1089/ars.2013.5347389470123642014Search in Google Scholar
Kwong C, Gilman-Sachs A, Beaman K. Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes. J Immunol Res. 2011; 186:1781–9.KwongCGilman-SachsABeamanKTumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytesJ Immunol Res20111861781910.4049/jimmunol.100299821178005Search in Google Scholar
Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol. 2009; 10:461–70.VirginHWLevineBAutophagy genes in immunityNat Immunol2009104617010.1038/ni.1726271536519381141Search in Google Scholar
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860–7.CoussensLMWerbZInflammation and cancerNature20024206917860710.1038/nature01322280303512490959Search in Google Scholar
Maiuri M, Tasdemir E, Criollo A, Morselli E, Vicencio J, Carnuccio R, Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009; 16:87–93.MaiuriMTasdemirECriolloAMorselliEVicencioJCarnuccioRKroemerGControl of autophagy by oncogenes and tumor suppressor genesCell Death Differ200916879310.1038/cdd.2008.13118806760Search in Google Scholar
Negi S, Chaudhuri A, Kumar DN, Dehari D, Singh S, Agrawal AK. Nanotherapeutics in autophagy: a paradigm shift in cancer treatment. Drug Deliv Transl Res. 2022; doi: 10.1007/s13346-022-01125-6NegiSChaudhuriAKumarDNDehariDSinghSAgrawalAKNanotherapeutics in autophagy: a paradigm shift in cancer treatmentDrug Deliv Transl Res202210.1007/s13346-022-01125-635149969Open DOISearch in Google Scholar
Dower CM, Wills CA, Frisch SM, Wang H-G. Mechanisms and context underlying the role of autophagy in cancer metastasis. Autophagy. 2018; 14:1110–28.DowerCMWillsCAFrischSMWangH-GMechanisms and context underlying the role of autophagy in cancer metastasisAutophagy20181411102810.1080/15548627.2018.1450020610372029863947Search in Google Scholar
Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014; 14:611–22.SosaMSBragadoPAguirre-GhisoJAMechanisms of disseminated cancer cell dormancy: an awakening fieldNat Rev Cancer2014146112210.1038/nrc3793423070025118602Search in Google Scholar
Peng Y-F, Shi Y-H, Shen Y-H, Ding Z-B, Ke A-W, Zhou J, et al. Promoting colonization in metastatic HCC cells by modulation of autophagy. PLoS One. 2013; 8:74407. doi: 10.1371/journal.pone.0074407PengY-FShiY-HShenY-HDingZ-BKeA-WZhouJPromoting colonization in metastatic HCC cells by modulation of autophagyPLoS One201387440710.1371/journal.pone.0074407377285924058558Open DOISearch in Google Scholar
Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A. 2010; 107:18511–6.Scherz-ShouvalRWeidbergHGonenCWilderSElazarZOrenMp53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvationProc Natl Acad Sci U S A201010718511610.1073/pnas.1006124107297296720937856Search in Google Scholar
Ryan KM. p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. Eur J Cancer. 2011; 47:44–50.RyanKMp53 and autophagy in cancer: guardian of the genome meets guardian of the proteomeEur J Cancer201147445010.1016/j.ejca.2010.10.02021112207Search in Google Scholar
Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007; 7:295–308.SchubbertSShannonKBollagGHyperactive Ras in developmental disorders and cancerNat Rev Cancer2007729530810.1038/nrc210917384584Search in Google Scholar
Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou Y-H, Formstecher E, et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell. 2011; 144:253–67.BodemannBOOrvedahlAChengTRamRROuY-HFormstecherERalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assemblyCell20111442536710.1016/j.cell.2010.12.018303859021241894Search in Google Scholar
Corcelle E, Nebout M, Bekri S, Gauthier N, Hofman P, Poujeol P, et al. Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal–regulated kinase activity. Cancer Res. 2006; 66:6861–70.CorcelleENeboutMBekriSGauthierNHofmanPPoujeolPDisruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal–regulated kinase activityCancer Res20066668617010.1158/0008-5472.CAN-05-355716818664Search in Google Scholar
Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell. 2011; 42:23–35.ElgendyMSheridanCBrumattiGMartinSJOncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survivalMol Cell201142233510.1016/j.molcel.2011.02.00921353614Search in Google Scholar
Lippai M, Lőw P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int. 2014; 2014:832704. doi: 10.1155/2014/832704LippaiMLőwPThe role of the selective adaptor p62 and ubiquitin-like proteins in autophagyBiomed Res Int2014201483270410.1155/2014/832704407509125013806Open DOISearch in Google Scholar
Huang J, Duran A, Reina-Campos M, Valencia T, Castilla EA, Müller TD, et al. Adipocyte p62/SQSTM1 suppresses tumori-genesis through opposite regulations of metabolism in adipose tissue and tumor. Cancer Cell. 2018; 33:770–84.e6. doi: 10.1016/j.ccell.2018.03.001HuangJDuranAReina-CamposMValenciaTCastillaEAMüllerTDAdipocyte p62/SQSTM1 suppresses tumori-genesis through opposite regulations of metabolism in adipose tissue and tumorCancer Cell20183377084.e610.1016/j.ccell.2018.03.001589678629634950Open DOISearch in Google Scholar
Li S-S, Xu L-Z, Zhou W, Yao S, Wang C-L, Xia J-L, et al. p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Carcinogenesis. 2017; 38:1092–103.LiS-SXuL-ZZhouWYaoSWangC-LXiaJ-Lp62/SQSTM1 interacts with vimentin to enhance breast cancer metastasisCarcinogenesis201738109210310.1093/carcin/bgx099586232728968743Search in Google Scholar
Zou Z, Zhang J, Zhang H, Liu H, Li Z, Cheng D, et al. 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy. J Drug Target. 2014; 22:839–48.ZouZZhangJZhangHLiuHLiZChengD3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapyJ Drug Target2014228394810.3109/1061186X.2014.93687025019701Search in Google Scholar
Cirone M, Montani MSG, Granato M, Garufi A, Faggioni A, D'Orazi G. Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences. J Exp Clin Cancer Res. 2019; 38:262. doi: 10.1186/s13046-019-1275-zCironeMMontaniMSGGranatoMGarufiAFaggioniAD'OraziGAutophagy manipulation as a strategy for efficient anticancer therapies: possible consequencesJ Exp Clin Cancer Res20193826210.1186/s13046-019-1275-z657088831200739Open DOISearch in Google Scholar
Bai Z, Peng Y, Ye X, Liu Z, Li Y, Ma L. Autophagy and cancer treatment: four functional forms of autophagy and their therapeutic applications. J Zhejiang Univ Sci B. 2022; 23:89–101.BaiZPengYYeXLiuZLiYMaLAutophagy and cancer treatment: four functional forms of autophagy and their therapeutic applicationsJ Zhejiang Univ Sci B2022238910110.1631/jzus.B2100804886155935187884Search in Google Scholar
Linder B, Kögel D. Autophagy in cancer cell death. Biology (Basel). 2019; 8:82. doi: 10.3390/biology8040082LinderBKögelDAutophagy in cancer cell deathBiology (Basel)201988210.3390/biology8040082695618631671879Open DOISearch in Google Scholar
Ashrafizadeh M, Paskeh MD, Mirzaei S, Gholami MH, Zarrabi A, Hashemi F, et al. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res. 2022; 41:105. doi: 10.1186/s13046-022-02293-6AshrafizadehMPaskehMDMirzaeiSGholamiMHZarrabiAHashemiFTargeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseJ Exp Clin Cancer Res20224110510.1186/s13046-022-02293-6893920935317831Open DOISearch in Google Scholar
Jeda AS, Ghabeshi S, Jazaeri EO, Araiinejad M, Sheikholeslami F, Abdoli M, et al. Autophagy modulation and cancer combination therapy: a smart approach in cancer therapy. Cancer Treat Res Commun. 2022; 7:100512. doi: 10.1016/j.ctarc.2022.100512JedaASGhabeshiSJazaeriEOAraiinejadMSheikholeslamiFAbdoliMAutophagy modulation and cancer combination therapy: a smart approach in cancer therapyCancer Treat Res Commun2022710051210.1016/j.ctarc.2022.10051235026533Open DOISearch in Google Scholar
Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019; 9:1167–81.AmaravadiRKKimmelmanACDebnathJTargeting autophagy in cancer: recent advances and future directionsCancer Discov2019911678110.1158/2159-8290.CD-19-0292730685631434711Search in Google Scholar
Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res. 2012; 4:357–65.CarewJSKellyKRNawrockiSTAutophagy as a target for cancer therapy: new developmentsCancer Manag Res201243576510.2147/CMAR.S26133347414323091399Search in Google Scholar
Sharma K, Le N, Alotaibi M, Gewirtz DA. Cytotoxic autophagy in cancer therapy. Int J Mol Sci. 2014; 15:10034–51.SharmaKLeNAlotaibiMGewirtzDACytotoxic autophagy in cancer therapyInt J Mol Sci201415100345110.3390/ijms150610034410013824905404Search in Google Scholar
Thelen M, Wymann MP, Langen H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc Natl Acad Sci U S A. 1994; 91:4960–4.ThelenMWymannMPLangenHWortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytesProc Natl Acad Sci U S A1994914960410.1073/pnas.91.11.4960439098197165Search in Google Scholar
Wu Y-T, Tan H-L, Shui G, Bauvy C, Huang Q, Wenk MR, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010; 285:10850–61.WuY-TTanH-LShuiGBauvyCHuangQWenkMRDual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinaseJ Biol Chem2010285108506110.1074/jbc.M109.080796285629120123989Search in Google Scholar
Tran AT, Ramalinga M, Kedir H, Clarke R, Kumar D. Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells. Eur J Nutr. 2015; 54:265–72.TranATRamalingaMKedirHClarkeRKumarDAutophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cellsEur J Nutr2015542657210.1007/s00394-014-0707-y423320224830781Search in Google Scholar
Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol. 2012; 32:4410–8.ParrCCarzanigaRGentlemanSMVan LeuvenFWalterJSastreMGlycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor proteinMol Cell Biol2012324410810.1128/MCB.00930-12348615322927642Search in Google Scholar
Turkoz Uluer E, Kilicaslan Sonmez P, Akogullari D, Onal M, Tanriover G, Inan S. Do wortmannin and thalidomide induce apoptosis by autophagy inhibition in 4T1 breast cancer cells in vitro and in vivo? Am J Transl Res. 2021; 13:6236–47.Turkoz UluerEKilicaslan SonmezPAkogullariDOnalMTanrioverGInanSDo wortmannin and thalidomide induce apoptosis by autophagy inhibition in 4T1 breast cancer cells in vitro and in vivo?Am J Transl Res.202113623647Search in Google Scholar
Rao J, Mei L, Liu J, Tang X, Yin S, Xia C, et al. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention. Acta Biomater. 2019; 89:300–12.RaoJMeiLLiuJTangXYinSXiaCSize-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retentionActa Biomater2019893001210.1016/j.actbio.2019.03.02230878446Search in Google Scholar
Li C, Liu Y, Liu H, Zhang W, Shen C, Cho K, et al. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells. Cell Physiol Biochem. 2015; 35:1303–16.LiCLiuYLiuHZhangWShenCChoKImpact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cellsCell Physiol Biochem20153513031610.1159/00037395225721868Search in Google Scholar
Xu R, Ji Z, Xu C, Zhu J. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysis. Medicine. 2018; 97:e12912. doi: 10.1197/MD.0000000000012912XuRJiZXuCZhuJThe clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysisMedicine201897e1291210.1197/MD.0000000000012912Open DOISearch in Google Scholar
Mohsen S, Sobash PT, Algwaiz GF, Nasef N, Al-Zeidaneen SA, Karim NA. Autophagy agents in clinical trials for cancer therapy: a brief review. Curr Oncol. 2022; 29:1695–708.MohsenSSobashPTAlgwaizGFNasefNAl-ZeidaneenSAKarimNAAutophagy agents in clinical trials for cancer therapy: a brief reviewCurr Oncol202229169570810.3390/curroncol29030141894697435323341Search in Google Scholar
Jones TM, Espitia C, Wang W, Nawrocki ST, Carew JS. Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies. Cancer Commun (Lond). 2019; 39:72. doi: 10.1186/s40880-019-0418-0JonesTMEspitiaCWangWNawrockiSTCarewJSMoving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studiesCancer Commun (Lond)2019397210.1186/s40880-019-0418-0684250231706349Open DOISearch in Google Scholar
Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema K-J, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018; 14:1435–55.MautheMOrhonIRocchiCZhouXLuhrMHijlkemaK-JChloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusionAutophagy20181414355510.1080/15548627.2018.1474314610368229940786Search in Google Scholar
Zeh HJ, Bahary N, Boone BA, Singhi AD, Miller-Ocuin JL, Normolle DP, et al. A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients. Clin Cancer Res. 2020; 26:3126–34.ZehHJBaharyNBooneBASinghiADMiller-OcuinJLNormolleDPA randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patientsClin Cancer Res20202631263410.1158/1078-0432.CCR-19-4042808659732156749Search in Google Scholar
Li L-Q, Xie W-J, Pan D, Chen H, Zhang L. Inhibition of autophagy by bafilomycin A1 promotes chemosensitivity of gastric cancer cells. Tumor Biol. 2016; 37:653–9.LiL-QXieW-JPanDChenHZhangLInhibition of autophagy by bafilomycin A1 promotes chemosensitivity of gastric cancer cellsTumor Biol201637653910.1007/s13277-015-3842-z26242265Search in Google Scholar
Liu P-F, Tsai K-L, Hsu C-J, Tsai W-L, Cheng J-S, Chang H-W, et al. Drug repurposing screening identifies tioconazole as an ATG4 inhibitor that suppresses autophagy and sensitizes cancer cells to chemotherapy. Theranostics. 2018; 8:830–45.LiuP-FTsaiK-LHsuC-JTsaiW-LChengJ-SChangH-WDrug repurposing screening identifies tioconazole as an ATG4 inhibitor that suppresses autophagy and sensitizes cancer cells to chemotherapyTheranostics201888304510.7150/thno.22012577109729344310Search in Google Scholar
Chu J, Fu Y, Xu J, Zheng X, Gu Q, Luo X, et al. ATG4B inhibitor FMK-9a induces autophagy independent on its enzyme inhibition. Arch Biochem Biophys. 2018; 644:29–36.ChuJFuYXuJZhengXGuQLuoXATG4B inhibitor FMK-9a induces autophagy independent on its enzyme inhibitionArch Biochem Biophys2018644293610.1016/j.abb.2018.03.00129510087Search in Google Scholar
Zhang W, Xu W, Chen W, Zhou Q. Interplay of autophagy inducer rapamycin and proteasome inhibitor mg132 in reduction of foam cell formation and inflammatory cytokine expression. Cell Transplant. 2018; 27:1235–48.ZhangWXuWChenWZhouQInterplay of autophagy inducer rapamycin and proteasome inhibitor mg132 in reduction of foam cell formation and inflammatory cytokine expressionCell Transplant20182712354810.1177/0963689718786229643446830001636Search in Google Scholar
Huang S, Yang ZJ, Yu C, Sinicrope FA. Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1. J Biol Chem. 2011; 286:40002–12.HuangSYangZJYuCSinicropeFAInhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1J Biol Chem2011286400021210.1074/jbc.M111.297432322058521949121Search in Google Scholar
Chang L, Huang Z, Li S, Yao Z, Bao H, Wang Z, et al. A low dose of AZD8055 enhances radiosensitivity of nasopharyngeal carcinoma cells by activating autophagy and apoptosis. Am J Cancer Res. 2019; 9:1922–37.ChangLHuangZLiSYaoZBaoHWangZA low dose of AZD8055 enhances radiosensitivity of nasopharyngeal carcinoma cells by activating autophagy and apoptosisAm J Cancer Res20199192237Search in Google Scholar
Bao J, Liu B, Wu C. The prospects of therapeutic potential and drug development targeting autophagy in cancer. Autophagy: biology and diseases: Springer; 2020, p. 663–79. In: Li W, editor. Autophagy: biology and diseases. Beijing: Science Press, and Singapore: Springer Nature; 2020, p. 663–79. (Crusio WE, Lambris JD, Rezaei N, series editors, Adv Exp Med Biol., vol. 1207). doi: 10.1007/978-981-15-4272-5_49BaoJLiuBWuCThe prospects of therapeutic potential and drug development targeting autophagy in cancer. Autophagy: biology and diseasesSpringer202066379In:LiWeditor.Autophagy: biology and diseasesBeijingScience PressSingaporeSpringer Nature202066379(Crusio WE, Lambris JD, Rezaei N, series editors, Adv Exp Med Biol., vol. 1207).10.1007/978-981-15-4272-5_4932671784Open DOISearch in Google Scholar
Abu el Maaty MA, Wölfl S. Vitamin D as a novel regulator of tumor metabolism: insights on potential mechanisms and implications for anti-cancer therapy. Int J Mol Sci. 2017; 18:2184. doi: 10.3390/ijms18102184Abu el MaatyMAWölflSVitamin D as a novel regulator of tumor metabolism: insights on potential mechanisms and implications for anti-cancer therapyInt J Mol Sci201718218410.3390/ijms18102184566686529048387Open DOISearch in Google Scholar
Tian Y, Song W, Li D, Cai L, Zhao Y. Resveratrol as a natural regulator of autophagy for prevention and treatment of cancer. Onco Targets Ther. 2019; 12:8601–9.TianYSongWLiDCaiLZhaoYResveratrol as a natural regulator of autophagy for prevention and treatment of cancerOnco Targets Ther2019128601910.2147/OTT.S213043680253931802896Search in Google Scholar
Lin S-R, Fu Y-S, Tsai M-J, Cheng H, Weng C-F. Natural compounds from herbs that can potentially execute as autophagy inducers for cancer therapy. Int J Mol Sci. 2017; 18:1412. doi: 10.3390/ijms18071412LinS-RFuY-STsaiM-JChengHWengC-FNatural compounds from herbs that can potentially execute as autophagy inducers for cancer therapyInt J Mol Sci201718141210.3390/ijms18071412553590428671583Open DOISearch in Google Scholar
Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front Pharmacol. 2020; 11:408. doi: 10.3389/fphar.2020.00408LiuTZhangJLiKDengLWangHCombination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapyFront Pharmacol20201140810.3389/fphar.2020.00408715697032322202Open DOISearch in Google Scholar
Wang X, Li Y, Jia F, Cui X, Pan Z, Wu Y. Boosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-modulator GO-Alg@CaP/CO. J Nanobiotechnology. 2022; 20:225. doi: 10.1186/s12951-022-01439-0WangXLiYJiaFCuiXPanZWuYBoosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-modulator GO-Alg@CaP/COJ Nanobiotechnology20222022510.1186/s12951-022-01439-0909704635551609Open DOISearch in Google Scholar
Mani J, Vallo S, Rakel S, Antonietti P, Gessler F, Blaheta R, et al. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (−)-Gossypol (AT-101). BMC Cancer. 2015; 15:224. doi: 10.1186/s12885-015-1239-4ManiJValloSRakelSAntoniettiPGesslerFBlahetaRChemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (−)-Gossypol (AT-101)BMC Cancer20151522410.1186/s12885-015-1239-4440972525885284Open DOISearch in Google Scholar
Yuan N, Song L, Zhang S, Lin W, Cao Y, Xu F, et al. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica. 2015; 100:345–56.YuanNSongLZhangSLinWCaoYXuFBafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemiaHaematologica20151003455610.3324/haematol.2014.113324434927325512644Search in Google Scholar
Kumar A, Singh UK, Chaudhary A. Targeting autophagy to overcome drug resistance in cancer therapy. Future Med Chem. 2015; 7:1535–42.KumarASinghUKChaudharyATargeting autophagy to overcome drug resistance in cancer therapyFuture Med Chem2015715354210.4155/fmc.15.8826334206Search in Google Scholar
Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014; 74:647–51.GewirtzDAThe four faces of autophagy: implications for cancer therapyCancer Res2014746475110.1158/0008-5472.CAN-13-296624459182Search in Google Scholar
Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013; 4:e838. doi: 10.1038/cddis.2013.350SuiXChenRWangZHuangZKongNZhangMAutophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death Dis20134e83810.1038/cddis.2013.350382466024113172Open DOISearch in Google Scholar
Zarzynska JM. The importance of autophagy regulation in breast cancer development and treatment. Biomed Res Int. 2014; 2014:710345. doi: 10.1155/2014/710345ZarzynskaJMThe importance of autophagy regulation in breast cancer development and treatmentBiomed Res Int2014201471034510.1155/2014/710345418206825317422Open DOISearch in Google Scholar
Eberhart K, Oral O, Gozuacik D. Chapter 13. Induction of autophagic cell death by anticancer agents. In: Hayat MA, editor. Autophagy: cancer, other pathologies, inflammation, immunity, infection, and aging vol. 1: molecular mechanisms. San Diego: Academic Press Elsevier; 2014, p. 179–202.EberhartKOralOGozuacikDChapter 13. Induction of autophagic cell death by anticancer agentsIn:HayatMAeditor.Autophagy: cancer, other pathologies, inflammation, immunity, infection, and aging vol. 1: molecular mechanismsSan DiegoAcademic Press Elsevier201417920210.1016/B978-0-12-405530-8.00013-3Search in Google Scholar
Munson MJ, Ganley IG. MTOR, PIK3C3, and autophagy: signaling the beginning from the end. Autophagy. 2015; 11:2375–6.MunsonMJGanleyIGMTOR, PIK3C3, and autophagy: signaling the beginning from the endAutophagy2015112375610.1080/15548627.2015.1106668483521126565689Search in Google Scholar
Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta. 2010; 1804:433–9.DowlingRJTopisirovicIFonsecaBDSonenbergNDissecting the role of mTOR: lessons from mTOR inhibitorsBiochim Biophys Acta20101804433910.1016/j.bbapap.2009.12.00120005306Search in Google Scholar
Rahman MA, Rahman MDH, Hossain MS, Biswas P, Islam R, Uddin MJ, et al. Molecular insights into the multifunctional role of natural compounds: autophagy modulation and cancer prevention. Biomedicines. 2020; 8:517. doi: 10.3390/biomedicines8110517RahmanMARahmanMDHHossainMSBiswasPIslamRUddinMJMolecular insights into the multifunctional role of natural compounds: autophagy modulation and cancer preventionBiomedicines2020851710.3390/biomedicines8110517769959633228222Open DOISearch in Google Scholar
Ramlee MK, Wang J, Toh WX, Li S. Transcription regulation of the human telomerase reverse transcriptase (hTERT) gene. Genes. 2016; 7:50. doi: 10.3390/genes7080050RamleeMKWangJTohWXLiSTranscription regulation of the human telomerase reverse transcriptase (hTERT) geneGenes201675010.3390/genes7080050499983827548225Open DOISearch in Google Scholar
Yang R, Dong H, Jia S, Yang Z. Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy. Clin Transl Oncol. 2022; 24:1219–30.YangRDongHJiaSYangZResveratrol as a modulatory of apoptosis and autophagy in cancer therapyClin Transl Oncol20222412193010.1007/s12094-021-02770-y35038152Search in Google Scholar
Vela L, Marzo I. Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside. Curr Opin Pharmacol. 2015; 23:74–81.VelaLMarzoIBcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedsideCurr Opin Pharmacol201523748110.1016/j.coph.2015.05.01426079328Search in Google Scholar
Paskeh MD, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, et al. Targeted regulation of autophagy using nanoparticles: new insight into cancer therapy. Biochim Biophys Acta Mol Basis Dis. 2022; 1868:166326. doi: 10.1016/j.bdadis.2021.166326PaskehMDEntezariMClarkCZabolianARanjbarEFarahaniMVTargeted regulation of autophagy using nanoparticles: new insight into cancer therapyBiochim Biophys Acta Mol Basis Dis2022186816632610.1016/j.bdadis.2021.166326Open DOISearch in Google Scholar
Kadkhoda J, Tarighatnia A, Tohidkia MR, Nader ND, Aghanejad A. Photothermal therapy-mediated autophagy in breast cancer treatment: progress and trends. Life Sci. 2022; 25:120499. doi: 10.1016/j.lfs.2022.120499KadkhodaJTarighatniaATohidkiaMRNaderNDAghanejadAPhotothermal therapy-mediated autophagy in breast cancer treatment: progress and trendsLife Sci20222512049910.1016/j.lfs.2022.12049935346674Open DOISearch in Google Scholar